Completed NCT00604279
This study is completed in China. It is testing Paliperidone Palmitate and Risperidone Long Acting Injection (LAI) for schizophrenia.
Multiple locations, including Baoding Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance. Over 18 Years
Countries China
Sponsor Xian-Janssen Pharmaceutical Ltd.
Condition Schizophrenia Completed NCT01086748
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Escondido Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States, Croatia, Russia
Sponsor Denovo Biopharma LLC
Condition Schizophrenia Completed NCT00034905
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Birmingham Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor AstraZeneca
Condition Schizophrenia Completed NCT00044044
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Birmingham Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 64 Years
Countries United States
Sponsor Sumitomo Pharma America, Inc.
Condition Schizophrenia Completed NCT00249223
This study is completed. It focuses on schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries
Sponsor Janssen Pharmaceutica N.V., Belgium
Condition Schizophrenia Completed NCT00843687
This study is completed. It focuses on schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 55 Years
Countries
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition Schizophrenia Active Not Recruiting NCT07618767
This summary needs review. Please check the official study record and contact the research team for details.
In Taipei Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Observational i A study where researchers collect information without assigning a treatment. Over 18 Years
Countries Taiwan
Sponsor National Taiwan University Hospital
Condition Schizophrenia Completed NCT01451164
This summary needs review. Please check the official study record and contact the research team for details.
In Kanto Region Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries Japan
Sponsor Otsuka Pharmaceutical Co., Ltd.
Condition Schizophrenia Completed NCT00686140
This study is completed in China. It focuses on schizophrenia.
In Beijing Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries China
Sponsor Beijing HuiLongGuan Hospital
Condition Schizophrenia Completed NCT00168311
This study is completed in Australia. It is testing Double-Blind Placebo Controlled Trial of Repetitive Transcranial Magnetic Stimulation in the Treatment of Negative Symptoms for schizophrenia.
In Melbourne Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Device i A study involving a tool, app, wearable, test, or medical device. From 18 Years to 70 Years
Countries Australia
Sponsor The Alfred
Condition Schizophrenia Completed NCT02008773
This study is completed in the United States. It focuses on schizophrenia.
Multiple locations, including Bellflower Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 40 Years
Countries United States
Sponsor Indiana University
Condition Schizophrenia Completed NCT00518323
This study is completed in the United States, in India, in Romania, .... It is testing Safety and Efficacy of Paliperidone Extended Release (ER) for schizophrenia.
Multiple locations, including Cerritos Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 12 Years to 17 Years
Countries United States, India, Romania, ...
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition Schizophrenia